A Potential Effect of Circadian Rhythm in the Delivery/Therapeutic Performance of Paclitaxel-Dendrimer Nanosystems

Overview

Journal J Funct Biomater

Specialty Biomedical Engineering

Date 2023 Jul 28

PMID 37504857

Authors

Tania Albuquerque

Ana Raquel Neves

Milan Paul

Swati Biswas

Elena Vuelta

Ignacio Garcia-Tunon

Manuel Sanchez-Martin

Telma Quintela

Diana Costa

Affiliations

Soon will be listed here.

Abstract

The circadian clock controls behavior and physiology. Presently, there is clear evidence of a connection between this timing system and cancer development/progression. Moreover, circadian rhythm consideration in the therapeutic action of anticancer drugs can enhance the effectiveness of cancer therapy. Nanosized drug delivery systems (DDS) have been demonstrated to be suitable engineered platforms for drug targeted/sustained release. The investigation of the chronobiology-nanotechnology relationship, i.e., timing DDS performance according to a patient's circadian rhythm, may greatly improve cancer clinical outcomes. In the present work, we synthesized nanosystems based on an octa-arginine (R8)-modified poly(amidoamine) dendrimer conjugated with the anticancer drug paclitaxel (PTX), G4-PTX-R8, and its physicochemical properties were revealed to be appropriate for in vitro delivery. The influence of the circadian rhythm on its cellular internalization efficiency and potential therapeutic effect on human cervical cancer cells (HeLa) was studied. Cell-internalized PTX and caspase activity, as a measure of induced apoptosis, were monitored for six time points. Higher levels of PTX and caspase-3/9 were detected at T8, suggesting that the internalization of G4-PTX-R8 into HeLa cells and apoptosis are time-specific/-regulated phenomena. For a deeper understanding, the clock protein Bmal1-the main regulator of rhythmic activity, was silenced by Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology. Bmal1 silencing was revealed to have an impact on both PTX release and caspase activity, evidencing a potential role for circadian rhythm on drug delivery/therapeutic effect mediated by G4-PTX-R8.

References

Slat E, Sponagel J, Marpegan L, Simon T, Kfoury N, Kim A . Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma. J Biol Rhythms. 2017; 32(2):121-129. PMC: 6410359. DOI: 10.1177/0748730417696788. View

Khatri S, G Das N, Das S . Effect of methotrexate conjugated PAMAM dendrimers on the viability of MES-SA uterine cancer cells. J Pharm Bioallied Sci. 2014; 6(4):297-302. PMC: 4231390. DOI: 10.4103/0975-7406.142963. View

Innominato P, Ballesta A, Huang Q, Focan C, Chollet P, Karaboue A . Sex-dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial. Cancer Med. 2020; 9(12):4148-4159. PMC: 7300418. DOI: 10.1002/cam4.3056. View

Neves A, Albuquerque T, Faria R, Goncalves A, Santos C, Vives E . Development of WRAP5 Peptide Complexes for Targeted Drug/Gene Co-Delivery toward Glioblastoma Therapy. Pharmaceutics. 2022; 14(10). PMC: 9607428. DOI: 10.3390/pharmaceutics14102213. View

Sadiq Z, Varghese E, Busselberg D . Cisplatin's dual-effect on the circadian clock triggers proliferation and apoptosis. Neurobiol Sleep Circadian Rhythms. 2020; 9:100054. PMC: 7752721. DOI: 10.1016/j.nbscr.2020.100054. View

Qu M, Zhang G, Qu H, Vu A, Wu R, Tsukamoto H . Circadian regulator BMAL1::CLOCK promotes cell proliferation in hepatocellular carcinoma by controlling apoptosis and cell cycle. Proc Natl Acad Sci U S A. 2023; 120(2):e2214829120. PMC: 9926257. DOI: 10.1073/pnas.2214829120. View

Morales-Cano D, Calvino E, Rubio V, Herraez A, Sancho P, Tejedor M . Apoptosis induced by paclitaxel via Bcl-2, Bax and caspases 3 and 9 activation in NB4 human leukaemia cells is not modulated by ERK inhibition. Exp Toxicol Pathol. 2013; 65(7-8):1101-8. DOI: 10.1016/j.etp.2013.04.006. View

Hanley K, Liang Y, Wang G, Lin X, Yang M, Karin M . Concurrent Disruption of the Ras/MAPK and NF-κB Pathways Induces Circadian Deregulation and Hepatocarcinogenesis. Mol Cancer Res. 2021; 20(3):337-349. PMC: 8898265. DOI: 10.1158/1541-7786.MCR-21-0479. View

Majoros I, Myc A, Thomas T, Mehta C, Baker Jr J . PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Biomacromolecules. 2006; 7(2):572-9. DOI: 10.1021/bm0506142. View

10.

Hu J, Fu S, Peng Q, Han Y, Xie J, Zan N . Paclitaxel-loaded polymeric nanoparticles combined with chronomodulated chemotherapy on lung cancer: In vitro and in vivo evaluation. Int J Pharm. 2016; 516(1-2):313-322. DOI: 10.1016/j.ijpharm.2016.11.047. View

11.

Valsalakumari R, Yadava S, Szwed M, Pandya A, Maelandsmo G, Torgersen M . Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells. Int J Pharm. 2021; 597:120217. DOI: 10.1016/j.ijpharm.2021.120217. View

12.

Neves A, Albuquerque T, Faria R, Paul M, Biswas S, Sousa A . Development of Tailor-Made Dendrimer Ternary Complexes for Drug/Gene Co-Delivery in Cancer. Pharmaceutics. 2021; 13(8). PMC: 8401607. DOI: 10.3390/pharmaceutics13081256. View

13.

Gavas S, Quazi S, Karpinski T . Nanoparticles for Cancer Therapy: Current Progress and Challenges. Nanoscale Res Lett. 2021; 16(1):173. PMC: 8645667. DOI: 10.1186/s11671-021-03628-6. View

14.

Lee Y, Fong S, Shon J, Zhang S, Brooks R, Lahens N . Time-of-day specificity of anticancer drugs may be mediated by circadian regulation of the cell cycle. Sci Adv. 2021; 7(7). PMC: 7880601. DOI: 10.1126/sciadv.abd2645. View

15.

Yu F, Zhang T, Zhou C, Xu H, Guo L, Chen M . The Circadian Clock Gene Controls Intestinal Exporter MRP2 and Drug Disposition. Theranostics. 2019; 9(10):2754-2767. PMC: 6568180. DOI: 10.7150/thno.33395. View

16.

Tang Q, Cheng B, Xie M, Chen Y, Zhao J, Zhou X . Circadian Clock Gene Bmal1 Inhibits Tumorigenesis and Increases Paclitaxel Sensitivity in Tongue Squamous Cell Carcinoma. Cancer Res. 2016; 77(2):532-544. DOI: 10.1158/0008-5472.CAN-16-1322. View

17.

Lossi L, Castagna C, Merighi A . Caspase-3 Mediated Cell Death in the Normal Development of the Mammalian Cerebellum. Int J Mol Sci. 2018; 19(12). PMC: 6321612. DOI: 10.3390/ijms19123999. View

18.

Wang X, Qiu Y, Wang M, Zhang C, Zhang T, Zhou H . Endocytosis and Organelle Targeting of Nanomedicines in Cancer Therapy. Int J Nanomedicine. 2020; 15:9447-9467. PMC: 7701161. DOI: 10.2147/IJN.S274289. View

19.

Miller A, Hicks M, Nakajima W, Richardson A, Windle J, Harada H . Paclitaxel-induced apoptosis is BAK-dependent, but BAX and BIM-independent in breast tumor. PLoS One. 2013; 8(4):e60685. PMC: 3618047. DOI: 10.1371/journal.pone.0060685. View

20.

Blanco E, Shen H, Ferrari M . Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015; 33(9):941-51. PMC: 4978509. DOI: 10.1038/nbt.3330. View